STERIS (STE) free cash flow

Free cash flow · fiscal 2026
$972.40M

STERIS (STE) generated free cash flow of $972.40M in fiscal 2026 (the year ended March 31, 2026). That is 25.0% higher than the $778.00M of fiscal 2025. Figures as of 18 Nov 2026, 11:57 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2026
$972.40M
Change on fiscal 2025
+25.0%
Growth, 5 years
+16.6% a year
Highest on record
$972.40Mfiscal 2026
Lowest on record
$251.19Mfiscal 2017
Fiscal years on record
102017–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

STERIS free cash flow, in more detail

Over the five fiscal years to 2026 free cash flow grew at a compound 16.6% a year. Across the 10 fiscal years on record (2017–2026), the highest was $972.40M in fiscal 2026 and the lowest $251.19M in fiscal 2017.

History · 10 fiscal years

Free cash flow by fiscal year

STERIS free cash flow, year by year

STERIS (STE) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2026$972.40M 25.0% up
2025$778.00M 26.9% up
2024$613.00M 55.2% up
2023$394.98M 0.6% down
2022$397.25M 11.8% down
2021$450.38M 19.8% up
2020$376.04M 7.5% up
2019$349.79M 19.7% up
2018$292.18M 16.3% up
2017$251.19M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of STERIS and comparable companies
CompanyFree cash flowFiscal year
STERIS STE$972.40M2026
Insmed INSM-$967.58M2025
United Therapeutics UTHR$1.04B2025
Incyte INCY$1.33B2025
Viatris VTRS$1.85B2025
Tenet Healthcare THC$2.53B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on STE

STERIS, figure by figure

STERIS (STE) overview: price, valuation and scorecardAll health care companies by market value

STERIS free cash flow: questions and answers

What is STERIS's free cash flow?

STERIS (STE) generated free cash flow of $972.40M in fiscal 2026 (the year ended March 31, 2026). That is 25.0% higher than the $778.00M of fiscal 2025.

What is the growth rate of STERIS's free cash flow?

Over the five fiscal years to 2026 free cash flow grew at a compound 16.6% a year.

What are the highest and lowest free cash flow figures on record for STERIS?

Across the 10 fiscal years on record (2017–2026), the highest was $972.40M in fiscal 2026 and the lowest $251.19M in fiscal 2017.

How is STERIS's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For STERIS it is on record here for 10 fiscal years, 2017 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “STERIS (STE) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/STE/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.